title: Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.
abstract: BACKGROUND
  Menopausal status and use of hormonal contraception or menopausal hormone therapy (HT) may affect treatment response to selective serotonin reuptake inhibitors (SSRIs). This report evaluates whether menopausal status and use of hormonal contraceptives or menopausal HT affect outcome in women treated with citalopram.
  
  
  METHODS
  In the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, 896 premenopausal and 544 postmenopausal women were treated with citalopram for 12-14 weeks. Baseline demographic and clinical characteristics were used in adjusted analysis of the effect of menopausal status and use of hormonal contraceptives or menopausal HT on outcomes. Remission was defined as final Hamilton Rating Scale for Depression-17 (HRSD(17)) ≤7 or Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR(16)) score ≤5 and response as ≥50% decrease from the baseline QIDS-SR(16) score.
  
  
  RESULTS
  Premenopausal and postmenopausal women differed in multiple clinical and demographic baseline variables but did not differ in response or remission rates. Premenopausal women taking hormonal contraceptives had significantly greater unadjusted remission rates on the HRSD(17) and the QIDS-SR(16) than women not taking contraception. Response and remission rates were not different between postmenopausal women taking vs. not taking HT. Adjusted results showed no significant difference in any outcome measure across menopause status in women who were not taking contraception/HT. There were no significant differences in adjusted results across HT status in premenopausal or postmenopausal women.
  
  
  CONCLUSIONS
  In this study, citalopram treatment outcome was not affected by menopausal status. Hormonal contraceptives and HT also did not affect probability of good outcome.
authors: Department of Psychiatry and Institute for Women's Health, Virginia Commonwealth University, Richmond, VA 23298-0710, USA. skornste@vcu.edu
authors: Susan G
authors: SG
authors: Kornstein
authors: Marisa
authors: M
authors: Toups
authors: A John
authors: AJ
authors: Rush
authors: Stephen R
authors: SR
authors: Wisniewski
authors: Michael E
authors: ME
authors: Thase
authors: James
authors: J
authors: Luther
authors: Diane
authors: D
authors: Warden
authors: Maurizio
authors: M
authors: Fava
authors: Madhukar H
authors: MH
authors: Trivedi
mesh_terms: D000328:Adult; D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000627:therapeutic use*; D015283:Citalopram / Q000008:administration & dosage / Q000627:therapeutic use*; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D015914:Estrogen Replacement Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D016015:Logistic Models; D008593:Menopause / Q000187:drug effects / Q000523:psychology*; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D011446:Prospective Studies; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D012959:Socioeconomic Factors
chemical_list: D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram; D003278:Contraceptives, Oral, Hormonal; D017367:Selective Serotonin Reuptake Inhibitors
references: Compr Psychiatry. 2008 May-Jun;49(3):238-46
references: 18396182
references: Psychol Med. 1996 May;26(3):477-86
references: 8733206
references: Am J Psychiatry. 2000 Sep;157(9):1445-52
references: 10964861
references: J Am Geriatr Soc. 1968 May;16(5):622-6
references: 5646906
references: Psychoneuroendocrinology. 2007 Aug;32(7):843-53
references: 17629629
references: Am J Geriatr Psychiatry. 2001 Fall;9(4):393-9
references: 11739065
references: J Womens Health (Larchmt). 2005 Sep;14(7):609-16
references: 16181017
references: Ann Clin Psychiatry. 2006 Apr-Jun;18(2):91-8
references: 16754414
references: J Affect Disord. 2005 Jul;87(1):43-55
references: 15894381
references: MD Comput. 1999 May-Jun;16(3):64-8
references: 10439605
references: Med Care. 1992 Jun;30(6):473-83
references: 1593914
references: Am J Psychiatry. 2006 Jan;163(1):28-40
references: 16390886
references: Clin Trials. 2004;1(4):387-98
references: 16279277
references: J Psychiatr Pract. 2006 Mar;12(2):71-9
references: 16728903
references: J Clin Psychopharmacol. 2001 Oct;21(5):540-2
references: 11593086
references: Arch Gen Psychiatry. 2001 Aug;58(8):787-94
references: 11483146
references: Psychol Med. 2004 Oct;34(7):1299-308
references: 15697056
references: Psychiatry Res. 1986 May;18(1):65-87
references: 3737788
references: J Affect Disord. 2003 Mar;74(1):5-13
references: 12646294
references: Neuropsychopharmacology. 2007 Dec;32(12):2479-89
references: 17406651
references: J Nerv Ment Dis. 1974 Aug;159(2):120-30
references: 4850465
references: Br J Psychiatry. 2002 May;180:461-4
references: 11983645
references: JAMA. 2001 Feb 7;285(5):535-9
references: 11176854
references: Biol Psychiatry. 2003 Sep 1;54(5):573-83
references: 12946886
references: J Clin Psychopharmacol. 2003 Aug;23(4):405-7
references: 12920418
references: Psychol Med. 2004 Jan;34(1):73-82
references: 14971628
references: Menopause. 2010 Jul;17(4):828-39
references: 20616669
references: Control Clin Trials. 2004 Feb;25(1):119-42
references: 15061154
references: Eur Neuropsychopharmacol. 2001 Jun;11(3):227-32
references: 11418283
references: J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
references: 14399272
references: Psychopharmacol Bull. 1993;29(2):321-6
references: 8290681
references: J Clin Psychiatry. 2005 Aug;66(8):1002-11
references: 16086615
references: Psychiatr Serv. 1997 May;48(5):611-2
references: 9144814
references: Eur Neuropsychopharmacol. 2007 May-Jun;17(6-7):400-5
references: 17196795
references: J Affect Disord. 2000 Oct;60(1):1-11
references: 10940442
references: J Affect Disord. 2005 Aug;87(2-3):141-50
references: 15982748
references: J Affect Disord. 2006 Jul;93(1-3):53-60
references: 16549204
references: Psychiatr Clin North Am. 2003 Jun;26(2):457-94, x
references: 12778843